WHO ICTRP trial
Efficacy and safety of autologous adipose-derived vascular matrix components…
ChiCTR2500100729 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500100729 |
|---|---|
| Public title | Efficacy and safety of autologous adipose-derived vascular matrix components (SVF) for improving cardiac function in patients with acute myocardial infarction: a prospective, single-center, randomized controlled study |
| Scientific title | Efficacy and safety of autologous adipose-derived vascular matrix components (SVF) for improving cardiac function in patients with acute myocardial infarction: a prospective, single-center, randomized controlled study |
| Primary sponsor | The Second Affiliated Hospital of Air Force Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Acute myocardial infarction |
| Interventions | 10×10^5 cells/kg SVF was injected intravenously:10×10^5 cells/kg SVF was injected intravenously at 24h and one month after surgery;20×10^5cells/kg SVF was injected intravenously:20×10^5 cells/kg SVF was injected intravenously at 24h and one… |
| Registration date | Apr 14, 2025 |
| Target size | 10×10^5 cells/kg SVF was injected intravenously:5;20×10^5cells/kg SVF was… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: